Neuromuscular Disorders
Volume 18, Issue 1 , Pages 71-73 , January 2008

Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy

  • P. Garrood

      Affiliations

    • Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 191 2418636; fax: +44 191 2418770.
    • ,
  • M. Eagle

      Affiliations

    • Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    • ,
  • P.E. Jardine

      Affiliations

    • Bristol Children’s Hospital, Bristol BS2 8BJ, UK
    • ,
  • K. Bushby

      Affiliations

    • Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    • ,
  • V. Straub

      Affiliations

    • Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK

Received 28 June 2007 ,Revised 28 June 2007 ,Accepted 16 July 2007.

References 

  1. Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F. Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol. 2002;6(3):153–159
  2. Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2–4 April 2004, Naarden, The Netherlands. Neuromuscular Disorders 2004;14(8–9):526–34.
  3. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2006;4;[Systematic Review]
  4. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA. 1993;90(8):3710–3714
  5. Figarella-Branger D, Baeta Machado AM, Putzu GA, Malzac P, Voelckel MA, Pellissier JF. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. Acta Neuropathol. 1997;94(1):48–53
  6. Yokota R, Shirotani M, Kouchi I, et al. Subclinical Becker’s muscular dystrophy presenting with severe heart failure. Int Med. 2004;43(3):204–208
  7. Girshin M, Mukherjee J, Clowney R, Singer LP, Wasnick J. The postoperative cardiovascular arrest of a 5-year-old male: an initial presentation of Duchenne’s muscular dystrophy. Paediatr Anaesth. 2006;16(2):170–173
  8. Obata R, Yasumi Y, Suzuki A, Nakajima Y, Sato S. Rhabdomyolysis in association with Duchenne’s muscular dystrophy. Can J Anaesth. 1999;46(6):564–566
  9. Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician. 2002;65(5):907–912
  10. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol. 2004;18(1):37–52

PII: S0960-8966(07)00679-7

doi: 10.1016/j.nmd.2007.07.006

Neuromuscular Disorders
Volume 18, Issue 1 , Pages 71-73 , January 2008

Article Tools